MAIA Biotechnology Inc (MAIA) Stock Price

1.15 ▼ -0.03 (-2.54%)
Open: 1.21 Vol: 27.65K Day's range: 1.15 - 1.215 Sep 29, 15:59 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
MAIA Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 1.15▼ 1.17▼ 1.17▼ 1.22▼ 1.26▼
MA10 1.16▼ 1.17▼ 1.18▼ 1.29▼ 1.31▼
MA20 1.17▼ 1.18▼ 1.20▼ 1.31▼ 1.33▼
MA50 1.17▼ 1.21▼ 1.27▼ 1.33▼ 1.44▼
MA100 1.19▼ 1.27▼ 1.31▼ 1.34▼ 1.63▼
MA200 1.21▼ 1.31▼ 1.34▼ 1.49▼ 2.13▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.003▼ 0.001▲ 0.000▲ -0.021▼ -0.009▼
RSI 18.516▼ 28.318▼ 25.343▼ 33.678▼ 38.388▼
STOCH 8.333▼ 43.333     11.996▼ 13.158▼ 26.338    
WILL %R -100.000▼ -100.000▼ -100.000▼ -100.000▼ -100.000▼
CCI -111.594▼ -233.333▼ -152.415▼ -177.323▼ -172.078▼
Latest Filters Detected On MAIA
▲ GAP $MAIA Open Gap Up %2 Set Alert
▼ BREAK $MAIA Price Breaks 60 Days Low Set Alert
▼ BREAK $MAIA Price Breaks 30 Days Low Set Alert
▼ BREAK $MAIA Price Breaks 20 Days Low Set Alert
▼ BREAK $MAIA Price Breaks 10 Days Low Set Alert
CDL $MAIA Marubozu Candlestick Pattern Detected Set Alert
MAIA Biotechnology Inc News
MAIA Biotechnology Expands Pivotal Phase 3 THIO-104 Non-Small Cell Lung Cancer Trial into Spain and Portugal
Wednesday, September 23, 2026 04:00 AM
THIO-104 advances toward key 2027 interim survival analysis CHICAGO, Sept. 23, 2026 (GLOBE NEWSWIRE) -- (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company ...
MAIA Biotechnology (MAIA) Price Target Decreased by 13.32% to 12.38
Sunday, November 16, 2025 04:00 PM
The average one-year price target for MAIA Biotechnology (NYSEAM:MAIA) has been revised to $12.38 / share. This is a decrease of 13.32% from the prior estimate of $14.28 dated November 7, 2025. The ...
MAIA Biotechnology's Experimental Cancer Drug Shows Tripled Survival Vs. Standard Chemotherapy In Pretreated Lung Cancer Patients
Thursday, June 05, 2025 11:27 AM
MAIA Biotechnology, Inc. (NASDAQ:MAIA) on Thursday revealed updated data from its THIO-101 pivotal Phase 2 clinical trial. The trial is evaluating its lead clinical candidate, ateganosine (THIO), ...
MAIA historical stock data
date open high low close volume
29/09/26 1.21 1.215 1.15 1.15 657,805
28/09/26 1.23 1.2645 1.18 1.18 1,011,089
25/09/26 1.27 1.33 1.20 1.20 920,667
24/09/26 1.31 1.33 1.25 1.25 594,975
23/09/26 1.35 1.36 1.30 1.32 627,018
22/09/26 1.33 1.37 1.31 1.37 940,351
21/09/26 1.35 1.38 1.30 1.33 1,142,611
18/09/26 1.37 1.3977 1.31 1.31 468,246
17/09/26 1.44 1.45 1.36 1.40 649,182
16/09/26 1.35 1.42 1.34 1.40 907,366
Quote Details
52wk Low:0.87
52wk High:3.19
Vol:27.65K
Avg Vol(3m):11.2M
1Y Chng:-20.14%
1M Chng:-16.06%
Add to Watch List
More Information
Index N/A
Market Cap. 71.78M